APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ischemia Reperfusion Injury

Reperfusion injury or reperfusion insult, sometimes called ischemia-reperfusion injury (IRI) or reoxygenation injury, is the tissue damage caused when blood supply returns to tissue (re- + perfusion) after a period of ischemia or lack of oxygen (anoxia or hypoxia). The absence of oxygen and nutrients from blood during the ischemic period creates a condition in which the restoration of circulation results in inflammation and oxidative damage through the induction of oxidative stress rather than (or along with) restoration of normal function.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Reperfusion injury or reperfusion insult, sometimes called ischemia-reperfusion injury (IRI) or reoxygenation injury, is the tissue damage caused when blood supply returns to tissue (re- + perfusion) after a period of ischemia or lack of oxygen (anoxia or hypoxia). The absence of oxygen and nutrients from blood during the ischemic period creates a condition in which the restoration of circulation results in inflammation and oxidative damage through the induction of oxidative stress rather than (or along with) restoration of normal function.

Selected research

Market Structure

Global Ischemia Reperfusion Injury Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025190 pages

Choose your research edition.

Industry ResearchIschemia Reperfusion Injury Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Ischemia Reperfusion Injury Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Ischemia Reperfusion Injury Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ischemia Reperfusion Injury Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Ischemia Reperfusion Injury Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Reperfusion injury or reperfusion insult, sometimes called ischemia-reperfusion injury (IRI) or reoxygenation injury, is the tissue damage caused when blood supply returns to tissue (re- + perfusion) after a period of ischemia or lack of oxygen (anoxia or hypoxia). The absence of oxygen and nutrients from blood during the ischemic period creates a condition in which the restoration of circulation results in inflammation and oxidative damage through the induction of oxidative stress rather than (or along with) restoration of normal function.

Global Ischemia Reperfusion Injury key players include Angion Biomedica, Catalyst Biosciences, Ischemix Inc, etc.

North America is the largest market, with a share about 50%, followed by Europe, and Japan, both have a share over 20 percent.

Read the full market overview

In terms of product, Phase 2 is the largest segment, with a share about 40%. And in terms of application, the largest application is Kidney Injury, followed by Heart Injury, Intestine Injury, etc.

Report Includes

This report provides an overview of the global Ischemia Reperfusion Injury market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ischemia Reperfusion Injury and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ischemia Reperfusion Injury revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Ischemia Reperfusion Injury market size, projected growth trends, production technologies, key applications, and end-use industries.

Ischemia Reperfusion Injury Segment by Company

Angion Biomedica

Catalyst Biosciences

Ischemix Inc

Opsona Therapeutics

Pharming

TheraSource

Bolder Biotechnology

Corline Biomedical

Mifcortx

Balmes Transplantation

NovelMed Therapeutics

Hope Pharmaceuticals

Omeros Corp

Prothix

SBI Pharmaceuticals

Ischemia Reperfusion Injury Segment by Type

Phase 1

Phase 2

Preclinical

Ischemia Reperfusion Injury Segment by Application

Heart Injury

Kidney Injury

Intestine Injury

Other Injury

Ischemia Reperfusion Injury Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ischemia Reperfusion Injury market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ischemia Reperfusion Injury and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ischemia Reperfusion Injury.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Ischemia Reperfusion Injury in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ischemia Reperfusion Injury industry.

Chapter 3: Detailed analysis of Ischemia Reperfusion Injury companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ischemia Reperfusion Injuryrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ischemia Reperfusion Injury Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Phase 1 Table 3. Key Players of Phase 2 Table 4. Key Players of Preclinical Table 4. Global Ischemia Reperfusion Injury Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Heart Injury Table 6. Key Players of Kidney Injury Table 7. Key Players of Intestine Injury Table 8. Key Players of Other Injury Table 9. Global Ischemia Reperfusion Injury Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Ischemia Reperfusion Injury Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Ischemia Reperfusion Injury Market Share by Region (2021-2026) Table 12. Global Ischemia Reperfusion Injury Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Ischemia Reperfusion Injury Market Share by Region (2027-2032) Table 14. Ischemia Reperfusion Injury Industry Trends Table 15. Ischemia Reperfusion Injury Industry Drivers Table 16. Ischemia Reperfusion Injury Industry Opportunities and Challenges Table 17. Ischemia Reperfusion Injury Industry Restraints Table 18. Global Ischemia Reperfusion Injury Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Ischemia Reperfusion Injury Revenue Market Share by Company (2021-2026) Table 20. Global Ischemia Reperfusion Injury Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Ischemia Reperfusion Injury Key Company Head Office and Area Served Table 22. Global Ischemia Reperfusion Injury Company, Product Type & Application Table 23. Global Ischemia Reperfusion Injury Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Ischemia Reperfusion Injury by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Ischemia Reperfusion Injury Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Ischemia Reperfusion Injury Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Ischemia Reperfusion Injury Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Ischemia Reperfusion Injury Revenue Market Share by Type (2021-2026) Table 30. Global Ischemia Reperfusion Injury Revenue Market Share by Type (2027-2032) Table 31. Global Ischemia Reperfusion Injury Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Ischemia Reperfusion Injury Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Ischemia Reperfusion Injury Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Ischemia Reperfusion Injury Revenue Market Share by Application (2021-2026) Table 35. Global Ischemia Reperfusion Injury Revenue Market Share by Application (2027-2032) Table 36. Angion Biomedica Company Information Table 37. Angion Biomedica Business Overview Table 38. Angion Biomedica Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Angion Biomedica Ischemia Reperfusion Injury Product Portfolio Table 40. Angion Biomedica Recent Development Table 41. Catalyst Biosciences Company Information Table 42. Catalyst Biosciences Business Overview Table 43. Catalyst Biosciences Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Catalyst Biosciences Ischemia Reperfusion Injury Product Portfolio Table 45. Catalyst Biosciences Recent Development Table 46. Ischemix Inc Company Information Table 47. Ischemix Inc Business Overview Table 48. Ischemix Inc Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Ischemix Inc Ischemia Reperfusion Injury Product Portfolio Table 50. Ischemix Inc Recent Development Table 51. Opsona Therapeutics Company Information Table 52. Opsona Therapeutics Business Overview Table 53. Opsona Therapeutics Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Opsona Therapeutics Ischemia Reperfusion Injury Product Portfolio Table 55. Opsona Therapeutics Recent Development Table 56. Pharming Company Information Table 57. Pharming Business Overview Table 58. Pharming Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Pharming Ischemia Reperfusion Injury Product Portfolio Table 60. Pharming Recent Development Table 61. TheraSource Company Information Table 62. TheraSource Business Overview Table 63. TheraSource Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. TheraSource Ischemia Reperfusion Injury Product Portfolio Table 65. TheraSource Recent Development Table 66. Bolder Biotechnology Company Information Table 67. Bolder Biotechnology Business Overview Table 68. Bolder Biotechnology Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Bolder Biotechnology Ischemia Reperfusion Injury Product Portfolio Table 70. Bolder Biotechnology Recent Development Table 71. Corline Biomedical Company Information Table 72. Corline Biomedical Business Overview Table 73. Corline Biomedical Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Corline Biomedical Ischemia Reperfusion Injury Product Portfolio Table 75. Corline Biomedical Recent Development Table 76. Mifcortx Company Information Table 77. Mifcortx Business Overview Table 78. Mifcortx Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Mifcortx Ischemia Reperfusion Injury Product Portfolio Table 80. Mifcortx Recent Development Table 81. Balmes Transplantation Company Information Table 82. Balmes Transplantation Business Overview Table 83. Balmes Transplantation Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Balmes Transplantation Ischemia Reperfusion Injury Product Portfolio Table 85. Balmes Transplantation Recent Development Table 86. NovelMed Therapeutics Company Information Table 87. NovelMed Therapeutics Business Overview Table 88. NovelMed Therapeutics Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. NovelMed Therapeutics Ischemia Reperfusion Injury Product Portfolio Table 90. NovelMed Therapeutics Recent Development Table 91. Hope Pharmaceuticals Company Information Table 92. Hope Pharmaceuticals Business Overview Table 93. Hope Pharmaceuticals Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Hope Pharmaceuticals Ischemia Reperfusion Injury Product Portfolio Table 95. Hope Pharmaceuticals Recent Development Table 96. Omeros Corp Company Information Table 97. Omeros Corp Business Overview Table 98. Omeros Corp Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Omeros Corp Ischemia Reperfusion Injury Product Portfolio Table 100. Omeros Corp Recent Development Table 101. Prothix Company Information Table 102. Prothix Business Overview Table 103. Prothix Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. Prothix Ischemia Reperfusion Injury Product Portfolio Table 105. Prothix Recent Development Table 106. SBI Pharmaceuticals Company Information Table 107. SBI Pharmaceuticals Business Overview Table 108. SBI Pharmaceuticals Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. SBI Pharmaceuticals Ischemia Reperfusion Injury Product Portfolio Table 110. SBI Pharmaceuticals Recent Development Table 111. North America Ischemia Reperfusion Injury Market Size by Type (2021-2026) & (US$ Million) Table 112. North America Ischemia Reperfusion Injury Market Size by Type (2027-2032) & (US$ Million) Table 113. North America Ischemia Reperfusion Injury Market Size by Application (2021-2026) & (US$ Million) Table 114. North America Ischemia Reperfusion Injury Market Size by Application (2027-2032) & (US$ Million) Table 115. North America Ischemia Reperfusion Injury Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Ischemia Reperfusion Injury Market Size by Country (2021-2026) Table 117. North America Ischemia Reperfusion Injury Market Size by Country (2027-2032) Table 118. Europe Ischemia Reperfusion Injury Market Size by Type (2021-2026) & (US$ Million) Table 119. Europe Ischemia Reperfusion Injury Market Size by Type (2027-2032) & (US$ Million) Table 120. Europe Ischemia Reperfusion Injury Market Size by Application (2021-2026) & (US$ Million) Table 121. Europe Ischemia Reperfusion Injury Market Size by Application (2027-2032) & (US$ Million) Table 122. Europe Ischemia Reperfusion Injury Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Ischemia Reperfusion Injury Market Size by Country (2021-2026) Table 124. Europe Ischemia Reperfusion Injury Market Size by Country (2027-2032) Table 125. China Ischemia Reperfusion Injury Market Size by Type (2021-2026) & (US$ Million) Table 126. China Ischemia Reperfusion Injury Market Size by Type (2027-2032) & (US$ Million) Table 127. China Ischemia Reperfusion Injury Market Size by Application (2021-2026) & (US$ Million) Table 128. China Ischemia Reperfusion Injury Market Size by Application (2027-2032) & (US$ Million) Table 129. Asia Ischemia Reperfusion Injury Market Size by Type (2021-2026) & (US$ Million) Table 130. Asia Ischemia Reperfusion Injury Market Size by Type (2027-2032) & (US$ Million) Table 131. Asia Ischemia Reperfusion Injury Market Size by Application (2021-2026) & (US$ Million) Table 132. Asia Ischemia Reperfusion Injury Market Size by Application (2027-2032) & (US$ Million) Table 133. Asia Ischemia Reperfusion Injury Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Asia Ischemia Reperfusion Injury Market Size by Country (2021-2026) Table 135. Asia Ischemia Reperfusion Injury Market Size by Country (2027-2032) Table 136. South America, Middle East & Africa Ischemia Reperfusion Injury Market Size by Type (2021-2026) & (US$ Million) Table 137. South America, Middle East & Africa Ischemia Reperfusion Injury Market Size by Type (2027-2032) & (US$ Million) Table 138. South America, Middle East & Africa Ischemia Reperfusion Injury Market Size by Application (2021-2026) & (US$ Million) Table 139. South America, Middle East & Africa Ischemia Reperfusion Injury Market Size by Application (2027-2032) & (US$ Million) Table 140. South America, Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. South America, Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2021-2026) Table 142. South America, Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Ischemia Reperfusion Injury Product Image Figure 2. Global Ischemia Reperfusion Injury Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Ischemia Reperfusion Injury Market Share by Type: 2025 VS 2032 Figure 4. Phase 1 Image Figure 5. Phase 2 Image Figure 6. Preclinical Image Figure 7. Global Ischemia Reperfusion Injury Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Ischemia Reperfusion Injury Market Share by Application: 2025 VS 2032 Figure 9. Heart Injury Image Figure 10. Kidney Injury Image Figure 11. Intestine Injury Image Figure 12. Other Injury Image Figure 13. Global Ischemia Reperfusion Injury Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 15. Global Ischemia Reperfusion Injury Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Ischemia Reperfusion Injury Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Ischemia Reperfusion Injury Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Ischemia Reperfusion Injury Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Ischemia Reperfusion Injury Revenue Market Share by Type (2021-2032) Figure 22. Global Ischemia Reperfusion Injury Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Ischemia Reperfusion Injury Revenue Market Share by Application (2021-2032) Figure 24. North America Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 25. North America Ischemia Reperfusion Injury Market Share by Type (2021-2032) Figure 26. North America Ischemia Reperfusion Injury Market Share by Application (2021-2032) Figure 27. North America Ischemia Reperfusion Injury Market Share by Country (2021-2032) Figure 28. United States Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 29. Canada Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 31. Europe Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 32. Europe Ischemia Reperfusion Injury Market Share by Type (2021-2032) Figure 33. Europe Ischemia Reperfusion Injury Market Share by Application (2021-2032) Figure 34. Europe Ischemia Reperfusion Injury Market Share by Country (2021-2032) Figure 35. Germany Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 36. France Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 38. Italy Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 39. Russia Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 41. China Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 42. China Ischemia Reperfusion Injury Market Share by Type (2021-2032) Figure 43. China Ischemia Reperfusion Injury Market Share by Application (2021-2032) Figure 44. Asia Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 45. Asia Ischemia Reperfusion Injury Market Share by Type (2021-2032) Figure 46. Asia Ischemia Reperfusion Injury Market Share by Application (2021-2032) Figure 47. Asia Ischemia Reperfusion Injury Market Share by Country (2021-2032) Figure 48. Japan Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 52. India Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 53. Australia Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Ischemia Reperfusion Injury Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Ischemia Reperfusion Injury Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Ischemia Reperfusion Injury Market Share by Country (2021-2032) Figure 58. Brazil Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 63. UAE Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 65. Chile Ischemia Reperfusion Injury Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Phase 1
  • Phase 2
  • Preclinical
Applications
  • Heart Injury
  • Kidney Injury
  • Intestine Injury
  • Other Injury
Companies covered
  • Angion Biomedica
  • Catalyst Biosciences
  • Ischemix Inc
  • Opsona Therapeutics
  • Pharming
  • TheraSource
  • Bolder Biotechnology
  • Corline Biomedical
  • Mifcortx
  • Balmes Transplantation
  • NovelMed Therapeutics
  • Hope Pharmaceuticals
  • Omeros Corp
  • Prothix
  • SBI Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Ischemia Reperfusion Injury Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Phase 1
  5. 1.2.3 Phase 2
  6. 1.2.4 Preclinical
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Ischemia Reperfusion Injury Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Heart Injury
  10. 1.3.3 Kidney Injury
  11. 1.3.4 Intestine Injury
  12. 1.3.5 Other Injury
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Ischemia Reperfusion Injury Growth Trends by Region
  15. 1.5.1 Global Ischemia Reperfusion Injury Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Ischemia Reperfusion Injury Market Size by Region (2021-2026)
  17. 1.5.3 Ischemia Reperfusion Injury Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Ischemia Reperfusion Injury Market Dynamics
  1. 2.1 Ischemia Reperfusion Injury Industry Trends
  2. 2.2 Ischemia Reperfusion Injury Industry Drivers
  3. 2.3 Ischemia Reperfusion Injury Industry Opportunities and Challenges
  4. 2.4 Ischemia Reperfusion Injury Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Ischemia Reperfusion Injury Revenue by Company (2021-2026)
  2. 3.2 Global Ischemia Reperfusion Injury Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Ischemia Reperfusion Injury Key Company Head office and Area Served
  4. 3.4 Global Ischemia Reperfusion Injury Company, Product Type & Application
  5. 3.5 Global Ischemia Reperfusion Injury Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Ischemia Reperfusion Injury Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Ischemia Reperfusion Injury Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Ischemia Reperfusion Injury Tier 1, Tier 2, and Tier 3
4 Ischemia Reperfusion Injury Market by Type
  1. 4.1 Global Ischemia Reperfusion Injury Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Ischemia Reperfusion Injury Market Size by Type (2021-2032)
  3. 4.3 Global Ischemia Reperfusion Injury Market Size Share by Type (2021-2032)
5 Ischemia Reperfusion Injury Market by Application
  1. 5.1 Global Ischemia Reperfusion Injury Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Ischemia Reperfusion Injury Market Size by Application (2021-2032)
  3. 5.3 Global Ischemia Reperfusion Injury Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Angion Biomedica
  2. 6.1.1 Angion Biomedica Company Information
  3. 6.1.2 Angion Biomedica Business Overview
  4. 6.1.3 Angion Biomedica Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Angion Biomedica Ischemia Reperfusion Injury Product Portfolio
  6. 6.1.5 Angion Biomedica Recent Developments
  7. 6.2 Catalyst Biosciences
  8. 6.2.1 Catalyst Biosciences Company Information
  9. 6.2.2 Catalyst Biosciences Business Overview
  10. 6.2.3 Catalyst Biosciences Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Catalyst Biosciences Ischemia Reperfusion Injury Product Portfolio
  12. 6.2.5 Catalyst Biosciences Recent Developments
  13. 6.3 Ischemix Inc
  14. 6.3.1 Ischemix Inc Company Information
  15. 6.3.2 Ischemix Inc Business Overview
  16. 6.3.3 Ischemix Inc Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Ischemix Inc Ischemia Reperfusion Injury Product Portfolio
  18. 6.3.5 Ischemix Inc Recent Developments
  19. 6.4 Opsona Therapeutics
  20. 6.4.1 Opsona Therapeutics Company Information
  21. 6.4.2 Opsona Therapeutics Business Overview
  22. 6.4.3 Opsona Therapeutics Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Opsona Therapeutics Ischemia Reperfusion Injury Product Portfolio
  24. 6.4.5 Opsona Therapeutics Recent Developments
  25. 6.5 Pharming
  26. 6.5.1 Pharming Company Information
  27. 6.5.2 Pharming Business Overview
  28. 6.5.3 Pharming Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Pharming Ischemia Reperfusion Injury Product Portfolio
  30. 6.5.5 Pharming Recent Developments
  31. 6.6 TheraSource
  32. 6.6.1 TheraSource Company Information
  33. 6.6.2 TheraSource Business Overview
  34. 6.6.3 TheraSource Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 TheraSource Ischemia Reperfusion Injury Product Portfolio
  36. 6.6.5 TheraSource Recent Developments
  37. 6.7 Bolder Biotechnology
  38. 6.7.1 Bolder Biotechnology Company Information
  39. 6.7.2 Bolder Biotechnology Business Overview
  40. 6.7.3 Bolder Biotechnology Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Bolder Biotechnology Ischemia Reperfusion Injury Product Portfolio
  42. 6.7.5 Bolder Biotechnology Recent Developments
  43. 6.8 Corline Biomedical
  44. 6.8.1 Corline Biomedical Company Information
  45. 6.8.2 Corline Biomedical Business Overview
  46. 6.8.3 Corline Biomedical Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Corline Biomedical Ischemia Reperfusion Injury Product Portfolio
  48. 6.8.5 Corline Biomedical Recent Developments
  49. 6.9 Mifcortx
  50. 6.9.1 Mifcortx Company Information
  51. 6.9.2 Mifcortx Business Overview
  52. 6.9.3 Mifcortx Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Mifcortx Ischemia Reperfusion Injury Product Portfolio
  54. 6.9.5 Mifcortx Recent Developments
  55. 6.10 Balmes Transplantation
  56. 6.10.1 Balmes Transplantation Company Information
  57. 6.10.2 Balmes Transplantation Business Overview
  58. 6.10.3 Balmes Transplantation Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Balmes Transplantation Ischemia Reperfusion Injury Product Portfolio
  60. 6.10.5 Balmes Transplantation Recent Developments
  61. 6.11 NovelMed Therapeutics
  62. 6.11.1 NovelMed Therapeutics Company Information
  63. 6.11.2 NovelMed Therapeutics Business Overview
  64. 6.11.3 NovelMed Therapeutics Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 NovelMed Therapeutics Ischemia Reperfusion Injury Product Portfolio
  66. 6.11.5 NovelMed Therapeutics Recent Developments
  67. 6.12 Hope Pharmaceuticals
  68. 6.12.1 Hope Pharmaceuticals Company Information
  69. 6.12.2 Hope Pharmaceuticals Business Overview
  70. 6.12.3 Hope Pharmaceuticals Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Hope Pharmaceuticals Ischemia Reperfusion Injury Product Portfolio
  72. 6.12.5 Hope Pharmaceuticals Recent Developments
  73. 6.13 Omeros Corp
  74. 6.13.1 Omeros Corp Company Information
  75. 6.13.2 Omeros Corp Business Overview
  76. 6.13.3 Omeros Corp Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Omeros Corp Ischemia Reperfusion Injury Product Portfolio
  78. 6.13.5 Omeros Corp Recent Developments
  79. 6.14 Prothix
  80. 6.14.1 Prothix Company Information
  81. 6.14.2 Prothix Business Overview
  82. 6.14.3 Prothix Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Prothix Ischemia Reperfusion Injury Product Portfolio
  84. 6.14.5 Prothix Recent Developments
  85. 6.15 SBI Pharmaceuticals
  86. 6.15.1 SBI Pharmaceuticals Company Information
  87. 6.15.2 SBI Pharmaceuticals Business Overview
  88. 6.15.3 SBI Pharmaceuticals Ischemia Reperfusion Injury Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 SBI Pharmaceuticals Ischemia Reperfusion Injury Product Portfolio
  90. 6.15.5 SBI Pharmaceuticals Recent Developments
7 North America
  1. 7.1 North America Ischemia Reperfusion Injury Market Size (2021-2032)
  2. 7.2 North America Ischemia Reperfusion Injury Market Size by Type
  3. 7.2.1 North America Ischemia Reperfusion Injury Market Size by Type (2021-2026)
  4. 7.2.2 North America Ischemia Reperfusion Injury Market Size by Type (2027-2032)
  5. 7.2.3 North America Ischemia Reperfusion Injury Market Share by Type (2021-2032)
  6. 7.3 North America Ischemia Reperfusion Injury Market Size by Application
  7. 7.3.1 North America Ischemia Reperfusion Injury Market Size by Application (2021-2026)
  8. 7.3.2 North America Ischemia Reperfusion Injury Market Size by Application (2027-2032)
  9. 7.3.3 North America Ischemia Reperfusion Injury Market Share by Application (2021-2032)
  10. 7.4 North America Ischemia Reperfusion Injury Market Size by Country
  11. 7.4.1 North America Ischemia Reperfusion Injury Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Ischemia Reperfusion Injury Market Size by Country (2021-2026)
  13. 7.4.3 North America Ischemia Reperfusion Injury Market Size by Country (2027-2032)
  14. 7.4.4 North America Ischemia Reperfusion Injury Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Ischemia Reperfusion Injury Market Size (2021-2032)
  2. 8.2 Europe Ischemia Reperfusion Injury Market Size by Type
  3. 8.2.1 Europe Ischemia Reperfusion Injury Market Size by Type (2021-2026)
  4. 8.2.2 Europe Ischemia Reperfusion Injury Market Size by Type (2027-2032)
  5. 8.2.3 Europe Ischemia Reperfusion Injury Market Share by Type (2021-2032)
  6. 8.3 Europe Ischemia Reperfusion Injury Market Size by Application
  7. 8.3.1 Europe Ischemia Reperfusion Injury Market Size by Application (2021-2026)
  8. 8.3.2 Europe Ischemia Reperfusion Injury Market Size by Application (2027-2032)
  9. 8.3.3 Europe Ischemia Reperfusion Injury Market Share by Application (2021-2032)
  10. 8.4 Europe Ischemia Reperfusion Injury Market Size by Country
  11. 8.4.1 Europe Ischemia Reperfusion Injury Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Ischemia Reperfusion Injury Market Size by Country (2021-2026)
  13. 8.4.3 Europe Ischemia Reperfusion Injury Market Size by Country (2027-2032)
  14. 8.4.4 Europe Ischemia Reperfusion Injury Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Ischemia Reperfusion Injury Market Size (2021-2032)
  2. 9.2 China Ischemia Reperfusion Injury Market Size by Type
  3. 9.2.1 China Ischemia Reperfusion Injury Market Size by Type (2021-2026)
  4. 9.2.2 China Ischemia Reperfusion Injury Market Size by Type (2027-2032)
  5. 9.2.3 China Ischemia Reperfusion Injury Market Share by Type (2021-2032)
  6. 9.3 China Ischemia Reperfusion Injury Market Size by Application
  7. 9.3.1 China Ischemia Reperfusion Injury Market Size by Application (2021-2026)
  8. 9.3.2 China Ischemia Reperfusion Injury Market Size by Application (2027-2032)
  9. 9.3.3 China Ischemia Reperfusion Injury Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Ischemia Reperfusion Injury Market Size (2021-2032)
  2. 10.2 Asia Ischemia Reperfusion Injury Market Size by Type
  3. 10.2.1 Asia Ischemia Reperfusion Injury Market Size by Type (2021-2026)
  4. 10.2.2 Asia Ischemia Reperfusion Injury Market Size by Type (2027-2032)
  5. 10.2.3 Asia Ischemia Reperfusion Injury Market Share by Type (2021-2032)
  6. 10.3 Asia Ischemia Reperfusion Injury Market Size by Application
  7. 10.3.1 Asia Ischemia Reperfusion Injury Market Size by Application (2021-2026)
  8. 10.3.2 Asia Ischemia Reperfusion Injury Market Size by Application (2027-2032)
  9. 10.3.3 Asia Ischemia Reperfusion Injury Market Share by Application (2021-2032)
  10. 10.4 Asia Ischemia Reperfusion Injury Market Size by Country
  11. 10.4.1 Asia Ischemia Reperfusion Injury Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Ischemia Reperfusion Injury Market Size by Country (2021-2026)
  13. 10.4.3 Asia Ischemia Reperfusion Injury Market Size by Country (2027-2032)
  14. 10.4.4 Asia Ischemia Reperfusion Injury Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Ischemia Reperfusion Injury Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Ischemia Reperfusion Injury Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Ischemia Reperfusion Injury Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Ischemia Reperfusion Injury Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Ischemia Reperfusion Injury Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Ischemia Reperfusion Injury Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Ischemia Reperfusion Injury Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Ischemia Reperfusion Injury Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Ischemia Reperfusion Injury Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Ischemia Reperfusion Injury Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Ischemia Reperfusion Injury Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Ischemia Reperfusion Injury Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst